Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$9.85 - $13.24 $1,083 - $1,456
110 Added 0.64%
17,331 $205,000
Q3 2022

Nov 14, 2022

SELL
$9.39 - $16.99 $140 - $254
-15 Reduced 0.09%
17,221 $257,000
Q2 2022

Aug 15, 2022

SELL
$3.92 - $9.73 $155,953 - $387,098
-39,784 Reduced 69.77%
17,236 $155,000
Q1 2022

May 11, 2022

BUY
$5.31 - $8.7 $38,125 - $62,465
7,180 Added 14.41%
57,020 $427,000
Q2 2021

Aug 16, 2021

BUY
$7.82 - $9.3 $311,228 - $370,130
39,799 Added 396.36%
49,840 $404,000
Q1 2021

May 17, 2021

BUY
$7.47 - $12.34 $75,006 - $123,905
10,041 New
10,041 $88,000

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $585M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Veritable, L.P. Portfolio

Follow Veritable, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.